Эсфоглив-Мик Comb. drug капсулы

Land: Kirgizië

Taal: Russisch

Bron: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Werkstoffen:

Фосфолипиды + тринатрия глицирризинат

Beschikbaar vanaf:

Фармстандарт ОАО (Фармстандарт ОАО)

ATC-code:

A05BA

INN (Algemene Internationale Benaming):

Phospholipids + trinacria of the DGL

Dosering:

Comb. drug

farmaceutische vorm:

капсулы

Eenheden in pakket:

№50

Prescription-type:

по рецепту

Geproduceerd door:

УП "Минскинтеркапс" (Беларусь)

Product samenvatting:

ПЖВЛС: нет

Autorisatie datum:

2016-04-15

Productkenmerken

YTBEPxtNAIo
3auecrnre;rb
ArrpeKTopa
!euapraue
ooecneqeHl.rg
[I
IIKII
Mu
vg,
9 n
I,IH
C
T PYKIIUq
TI
O M EAI4III,I
H
C
KO MY IIPIIM E
HE
HITIO JIEK
IIPETIAPATA
HHOTO
SCOO|JIIIB.MI,IK
Topronoe
Ha3BaHr{e
3c(f ornran-MITIK
MexgyHapoAnoe
HerrareHToBauHoe
Ha3BaHrre
Her
JlercapcreeHHafl
Qoprvra
Kancyrur.
Cocran
O,qu
a KancyJra
coAeplrr,rr
Arcmuauute
6eu4ecmso.'
$oc$onuilr.AoB
-
65 rr,rr
(e
sule
Jrr4rror4Aa
II[JI-400
-
84,4 rvrr),
Tpr4Harpr4r
rnurlr4pplr3umara
-
3
5
ur.
BcnouozamerbHbte
6eu4ecmsai
BocK
nqeJrr{urrft,
uogcoJrHerrHoe
MacJro
pa(prauraponaHuoe.
Cocmae o6onoqrcu
Kancynbt:
xeJIarLrH,
rJrrrqepr.rH,
BoAa
oqvueHHas, Haffpvfl.6ensoar
E-2II,
TLrraHa
AuoKcI{A
E-17I, KpacI4TenI4:
xeJre3a
oKcr4A
rpacutrft
E-172,
xeJre3a
oKr.rA
xeJrrrrft
E-
IT2,xeteza
oKcr4,(
uepurrfi
E-I72,
Orucanue
Kancylu
MfirKI{e
xeJIarLIHoBbre
oBaJrbHoft
$oprr,ru
co rrrBoM,
ylpyrr{e,
cBerno-Kopr,rqneBofo
uBeTa.
@apvranoreparreBTrrrrecKaq
rpyrrrra
flpenaparrr
AJrr
JrerreHr.rs
s
a6oresauufi
ueqeuu.
Koa
ATX A05BA.
@apvraro"rrorrrqecKrre
csofi
crsa
,
(Dapnaxoduuanuxa
Korr,r6nHupoeaHurrfr
rpenapar.
OxagHeaer
uerr.r6pauoctaluttusupyroulee,
renaronporeKTopHoe
r{ nporr.rBoBr{pycHoe
Aeft
crnue.
Ooc(faru4I,IJIxoJIIzH
(ocHonuoe
Aeftcrsyroqee
BerrlecrBo
$oc$onunr.r4on)
.f,BJrflerct
crpyKTypHbIM
SJIeMeHToM
KJreroqHbx
u
BHyrpr,rKJreroqHhrx
uelr6paH,
cnoco6eu
BoccraHaBJII4Barb
I4x
crpyKTypy
u
Qyurqnu
npu
rroBpelK.qeHr4r4,
oKa3brBir.f,
rlr4TonporeKTopHoe
,4eftcrsue.
Hopuanusyer
6elroerrfi
u
rururagnrrft
o6ueurr,
[peAorBparqaer
rrorepro
rerlaro{I'ITarr,rn
SepnaeHToB
LI
Apyr[x
aKTr{BHbx
BerrlecrB,
BoccraHaBJrr4Baer
AeroKcr,rqupyrorUyrc
$yHItquro
[eqeHLI,
unru6upyer
o6pasonauue
coeAnHrrremuoft
TKaHr4,
cnvn1afl. pr4cK
Bo3Hr4
KHoBeuur
1p
rz6po3a
14
rlr,rppo3
a rreqeHr4.
fnrzqnpprasl,IHarbl
(rnuqnppu3I4HoBiur
KlrcJrora
u ee
conu)
o6raAalor
nporr.rBoBocnaJrr.rreJrbHbrM
4eftcrnueu,
noAaBJItIor
penpoAyKllr{rc
Br4pycoB
B
neqeHr.r
u
Apyrux
oprarrax
3a cqer
I*"":Z
d
cTLrMyJrrrIIII,I
[poAyKrlr4r4
r4HTep(bepoHoB,
rroBhrrrreHr4r
safoquTo3a,
yBeJII{qeHus.
aKTLIBHocTU
ecrecrBeHHhr